Researcher.Life Logo

Vascular Pharmacology : Impact Factor & More

eISSN: 1879-3649pISSN: 1537-1891

Key Metrics

CiteScore
10.3
Impact Factor
< 5
SJR
Q1Physiology
SNIP
1.47
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Vascular Pharmacology

Vascular Pharmacology Journal Specifications

Overview
Publisher ELSEVIER SCIENCE INC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2002
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Vascular Pharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Vascular Pharmacology

Hemodynamic markers: CFD-based prediction of cerebral aneurysm rupture risk.
  • 1 Mar 2026
  • Vascular pharmacology
Real-world observational study on pulmonary arterial hypertension: Italian cohort treated with macitentan and/or selexipag as a part of a combination treatment (INSPECTIO).
  • 1 Mar 2026
  • Vascular pharmacology
Endothelial-to-mesenchymal transition primes vascular endothelial cells toward an osteochondrogenic fate.
  • 1 Mar 2026
  • Vascular pharmacology
Smooth muscle cell phenotypic modulation during atherosclerosis.
  • 1 Mar 2026
  • Vascular pharmacology
Amylin receptors as therapeutic targets in obesity: Emerging peptide-based strategies.
  • 1 Mar 2026
  • Vascular pharmacology
RNA-seq and ChIP-seq reveal microplastics induce endothelial-mesenchymal transition via HK2-mediated histone lactylation in pulmonary hypertension.
  • 1 Mar 2026
  • Vascular pharmacology
Hemodynamic markers: CFD-based prediction of cerebral aneurysm rupture risk.
  • 1 Mar 2026
  • Vascular pharmacology
Real-world observational study on pulmonary arterial hypertension: Italian cohort treated with macitentan and/or selexipag as a part of a combination treatment (INSPECTIO).
  • 1 Mar 2026
  • Vascular pharmacology
Endothelial-to-mesenchymal transition primes vascular endothelial cells toward an osteochondrogenic fate.
  • 1 Mar 2026
  • Vascular pharmacology
Smooth muscle cell phenotypic modulation during atherosclerosis.
  • 1 Mar 2026
  • Vascular pharmacology
Amylin receptors as therapeutic targets in obesity: Emerging peptide-based strategies.
  • 1 Mar 2026
  • Vascular pharmacology
RNA-seq and ChIP-seq reveal microplastics induce endothelial-mesenchymal transition via HK2-mediated histone lactylation in pulmonary hypertension.
  • 1 Mar 2026
  • Vascular pharmacology

FAQs on Vascular Pharmacology